AlphaYouCCCC: Adams Kendra discloses securities transactions
By AlphaYouPublished Form 4
Adams Kendra
Reporting filer
Adams Kendra reported Exercise or conversion in C4 Therapeutics, Inc.: 6250 units of Common Stock, dated 2026-09-18. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 21, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Adams Kendra | 2026-09-18 | M | Exercise or conversion | 6250 | 0 | 385,098 | 3 days | Filed terms
|
| Common Stock | Adams Kendra | 2026-09-18 | F | Tax/exercise withholding | 2775 | 3.39 | 382,323 | 3 days | Filed terms
|
Common Stock
- Owner
- Adams Kendra
- Date
- 2026-09-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 6250
- Price
- 0
- Following holdings
- 385,098
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-18
- transaction Form Type: 5
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Timeliness: E
- transaction Shares: 6250
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 385098
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Adams Kendra
- Date
- 2026-09-18
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 2775
- Price
- 3.39
- Following holdings
- 382,323
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-18
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- id: F2
- transaction Shares: 2775
- transaction Price Per Share: 3.39
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 382323
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Adams Kendra: Chief Financial Officer.
- F1: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023.
- F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.